Objective To evaluate quality and current status of traditional Chinese medicine (TCM) guidelines and consensus, and to promote the improvements in the quality of guidelines and consensus. Methods A systematic collection of TCM guidelines and consensus published in medical journals in 2022 was conducted. We used scientific, transparent, and applicable ranking tools (STAR) for evaluation, analyzed the scoring rates (%), and assessed the quality level and influencing factors of guidelines and consensus through methods such as comparison and stratification. Results A total of 130 TCM guidelines and consensus were included. Guideline areas with higher scores included recommendations (65.3%), evidence (55.9%), and guideline development groups (54.2%). In the case of consensus, higher scores were observed in recommendations (38.7%), guideline development groups (37.0%), and funding (30.0%). The total score rate of TCM guidelines exceeded that of national guidelines, while the consensus rate was lower. Stratified analysis revealed statistical differences in guideline score rates among journals and issuing institutions, as well as significant differences in consensus score rates among journals, formulation institutions, subjects, and funding categories. Conclusion The quantity and quality of TCM guidelines and consensus are on a positive trajectory, with higher quality levels in guidelines than in consensus. The overall quality of TCM guidelines surpasses that of national guidelines, particularly emphasizing the scientificity of guideline formulation. However, the overall quality of consensus remains lower than that of the national consensus. Factors such as journals, formulation institutions, subjects, and funding categories are identified as potential influences on the quality of TCM guidelines and consensus.
Citation:
ZHANG Luan, WANG Yangyang, WANG Xu, XIE Runsheng, LI Su, CHEN Yaolong, LI Hui. Evaluation of the scientificity, transparency, and applicability of Chinese traditional medicine guidelines and consensus (2022). Chinese Journal of Evidence-Based Medicine, 2024, 24(8): 959-966. doi: 10.7507/1672-2531.202311101
Copy
Copyright © the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved
1. |
|
2. |
|
3. |
|
4. |
|
5. |
|
6. |
陈争光. 循证性中医临床实践指南制订的方法学研究. 南京: 南京中医药大学, 2012.
|
7. |
|
8. |
|
9. |
|
10. |
|
11. |
陈耀龙, 魏均民. STAR开启临床指南评价新篇章. 健康报, 2022.
|
12. |
|
13. |
|
14. |
|
15. |
|
16. |
|
17. |
|
18. |
陈耀龙. GRADE在系统评价和实践指南中的应用(第1版). 兰州: 兰州大学出版社, 2017.
|
19. |
|
20. |
|
21. |
|
22. |
|
23. |
|
24. |
|
25. |
|
26. |
|
27. |
|
28. |
|
- 1.
- 2.
- 3.
- 4.
- 5.
- 6. 陈争光. 循证性中医临床实践指南制订的方法学研究. 南京: 南京中医药大学, 2012.
- 7.
- 8.
- 9.
- 10.
- 11. 陈耀龙, 魏均民. STAR开启临床指南评价新篇章. 健康报, 2022.
- 12.
- 13.
- 14.
- 15.
- 16.
- 17.
- 18. 陈耀龙. GRADE在系统评价和实践指南中的应用(第1版). 兰州: 兰州大学出版社, 2017.
- 19.
- 20.
- 21.
- 22.
- 23.
- 24.
- 25.
- 26.
- 27.
- 28.
Journal type citation(9)
1. | 高璐,孔德昭,曹宇博,王思佳,张哲. 疏肝理气活血法治疗冠心病合并抑郁的网状Meta分析. 中西医结合心脑血管病杂志. 2025(04): 503-512 . Baidu Scholar | |
2. | 赖鸿皓,孙铭谣,李颖,黄嘉杰,刘佳宁,潘蓓,田金徽,葛龙. 维特鲁威图:一种直观展示证据汇总结果的可视化工具. 协和医学杂志. 2024(03): 668-675 . Baidu Scholar | |
3. | 黄嘉杰,赖鸿皓,刘佳宁,赵威龙,孙铭谣,叶紫莹,李颖,潘蓓,田金徽,栗梦婷,葛龙. 网状Meta分析证据确信度分级与结果解读:方法与案例. 中国循证医学杂志. 2024(10): 1231-1240 . View this site | |
4. | 苗雅楠,陶颖,李影,刘艳茹,王薇. 生物制剂治疗中重度斑块状银屑病患者长期有效性的网状Meta分析. 中国循证医学杂志. 2022(08): 917-925 . View this site | |
5. | 李其战,杨小兰. 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白联合甲氨蝶呤治疗活动性类风湿关节炎的效果. 中国医药科学. 2022(16): 73-76 . Baidu Scholar | |
6. | 陆瑶,杨秋玉,赖鸿皓,田晨,陈耀龙,田金徽,李霓,李江,葛龙. 诊断试验准确性比较研究系统评价的证据分级. 中国循证医学杂志. 2022(10): 1233-1240 . View this site | |
7. | 李蔼颖,孙妍,郑进,袁素平,张瑾. 不同健康教育模式对老年脑卒中患者干预效果的网状Meta分析. 中国老年保健医学. 2022(06): 49-53 . Baidu Scholar | |
8. | 朱鸿飞,栗梦婷,后亮瑛,王琪,田金徽,陈耀龙,杨克虎,邓宏勇,曾力楠,张伶俐,Romina Brignardello-Petersen,葛龙. 网状Meta分析结论形成的方法:部分背景化框架. 中国循证医学杂志. 2021(09): 1110-1116 . View this site | |
9. | 武珊珊,田金徽,杨智荣,刘凤琪,董圣杰,张天嵩,孙凤. 网络Meta分析研究进展系列(十八):网络Meta分析的GRADE证据分级. 中国循证心血管医学杂志. 2021(11): 1284-1288 . Baidu Scholar | |
Other types of references(5)
1. | 佘金龙. 中药联合玻璃体抗VEGF药物注射治疗RVO-ME疗效的贝叶斯网状荟萃分析[D]. 成都中医药大学. 2023. Baidu Scholar | |
2. | 陈聪慧. 中医传统运动疗法治疗稳定期COPD的网状Meta分析[D]. 湖北中医药大学. 2022. Baidu Scholar | |
3. | 闫松. 幽门螺杆菌检测方法诊断效能的网状Meta分析[D]. 华北理工大学. 2023. Baidu Scholar | |
4. | 朱鸿飞. 健康结局指标效应量决策阈值制定的方法学框架构建研究[D]. 兰州大学. 2023. Baidu Scholar | |
5. | 邓宇威. 不同促排卵方案治疗PCOS不孕症患者疗效的网状meta分析[D]. 成都中医药大学. 2023. Baidu Scholar | |